We are live on ! Find out more
OM icon

Outset Medical

161 hedge funds and large institutions have $957M invested in Outset Medical in 2023 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 59 increasing their positions, 41 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

132% more call options, than puts

Call options by funds: $723K | Put options by funds: $311K

98% more capital inflows, than outflows

Capital inflows: $145M | Capital outflows: $73.1M

58% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 19

44% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 41

6% more funds holding

Funds holding: 152 → 161 (+9)

5.43% more ownership

Funds ownership: 101.5% → 106.93% (+5.4%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
161
Holders Change
+9
Holders Change %
+5.92%
% of All Funds
2.56%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
30
Increased
59
Reduced
41
Closed
19
Calls
$723​K
Puts
$311​K
Net Calls
+$412​K
Net Calls Change
-⁠$9.28​M

OM Hedge Fund Activity: Q1 2023 in Review

161 of the 6,286 institutional investors tracked by Wall St. Rank reported a position in Outset Medical (OM) for Q1 2023, worth a combined $957M — down 24% from $1.27B a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new OM positions and 19 closed out — a net gain of 11 holders — while 59 added to existing stakes and 41 trimmed.

The largest buyer was Ameriprise, adding an estimated $18.6M. The largest seller was Barclays, cutting an estimated $10.2M.

  • 161 institutional investors held Outset Medical (OM) as of Q1 2023, up from 152 in Q4 2022.
  • Funds reported $957M of Outset Medical stock for Q1 2023, down 24% quarter-over-quarter.
  • 30 funds opened new Outset Medical positions in Q1 2023 and 19 closed out, a net change of +11 holders.
  • The largest Outset Medical buyer in Q1 2023 was Ameriprise, an estimated $18.6M added.
  • The largest Outset Medical seller in Q1 2023 was Barclays, an estimated $10.2M sold.

Based on aggregated 13F filings for Q1 2023.